Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Share-based Compensation (2023 - 2025)

Historic Share-based Compensation for SeaStar Medical Holding (ICUCW) over the last 3 years, with Q3 2025 value amounting to $290000.0.

  • SeaStar Medical Holding's Share-based Compensation rose 4500.0% to $290000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $767000.0, marking a year-over-year decrease of 2770.97%. This contributed to the annual value of $887000.0 for FY2024, which is 5404.15% down from last year.
  • According to the latest figures from Q3 2025, SeaStar Medical Holding's Share-based Compensation is $290000.0, which was up 4500.0% from $97000.0 recorded in Q2 2025.
  • SeaStar Medical Holding's Share-based Compensation's 5-year high stood at $555000.0 during Q2 2023, with a 5-year trough of $41000.0 in Q2 2024.
  • For the 3-year period, SeaStar Medical Holding's Share-based Compensation averaged around $306545.5, with its median value being $290000.0 (2025).
  • As far as peak fluctuations go, SeaStar Medical Holding's Share-based Compensation crashed by 9261.26% in 2024, and later skyrocketed by 13658.54% in 2025.
  • Quarter analysis of 3 years shows SeaStar Medical Holding's Share-based Compensation stood at $386000.0 in 2023, then plummeted by 45.08% to $212000.0 in 2024, then soared by 36.79% to $290000.0 in 2025.
  • Its Share-based Compensation was $290000.0 in Q3 2025, compared to $97000.0 in Q2 2025 and $168000.0 in Q1 2025.